Arbogast; Christophe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Arbogast; Christophe.The latest application filed is for "kdr and vegf/kdr binding peptides and their use in diagnosis and therapy".

Company Profile

0.12.13

Arbogast; Christophe - Viuz-en-Sallaz FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy Grant 9,446,155 - Sato , et al. September 20, 2	2016-09-20
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy Grant 9,408,926 - Arbogast , et al. August 9, 2	2016-08-09
Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy App 20140286864 - SATO; AARON K. ; et al.	2014-09-25
Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy App 20140161732 - ARBOGAST; Christophe ; et al.	2014-06-12
Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy App 20140107041 - SATO; AARON K. ; et al.	2014-04-17
Multivalent constructs for therapeutic and diagnostic applications Grant 8,663,603 - Arbogast , et al. March 4, 2	2014-03-04
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy Grant 8,642,010 - Sato , et al. February 4, 2	2014-02-04
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy Grant 8,623,822 - Arbogast , et al. January 7, 2	2014-01-07
Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy App 20110097275 - Arbogast; Christophe ; et al.	2011-04-28
Multivalent Constructs For Therapeutic And Diagnostic Applications App 20110070165 - Arbogast; Christophe ; et al.	2011-03-24
Multivalent constructs for therapeutic and diagnostic applications Grant 7,910,088 - Arbogast , et al. March 22, 2	2011-03-22
Multivalent constructs for therapeutic and diagnostic applications Grant 7,854,919 - Arbogast , et al. December 21, 2	2010-12-21
Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy App 20100003195 - Sato; Aaron K. ; et al.	2010-01-07
Multivalent Constructs For Therapeutic And Diagnostic Applications App 20070243139 - Arbogast; Christophe ; et al.	2007-10-18
Multivalent constructs for therapeutic and diagnostic applications Grant 7,261,876 - Arbogast , et al. August 28, 2	2007-08-28
Multivalent Constructs For Therapeutic And Diagnostic Applications App 20070172428 - Arbogast; Christophe ; et al.	2007-07-26
Multivalent constructs for therapeutic and diagnostic applications Grant 7,211,240 - Arbogast , et al. May 1, 2	2007-05-01
KDR and VEGF/KDR binding peptides App 20050250700 - Sato, Aaron K. ; et al.	2005-11-10
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy App 20050100963 - Sato, Aaron K. ; et al.	2005-05-12
Multivalent constructs for therapeutic and diagnostic applications App 20050027105 - Arbogast, Christophe ; et al.	2005-02-03
Multivalent constructs for therapeutic and diagnostic applications App 20040210041 - Arbogast, Christophe ; et al.	2004-10-21
Multivalent constructs for therapeutic and diagnostic applications App 20040018974 - Arbogast, Christophe ; et al.	2004-01-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.